PAOLO CASSANO

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry LEXINGTON, MA NPI 1700912136

General Payments — all program years on this page

$10,565.06

  • Category: General Payments
  • Program years: PY2019
  • Record count: 18
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $10,565.06 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $8,080.002
Travel and Lodging $2,099.044
Food and Beverage $386.0212

By paying entity

Latest program year (PY2019) · sorted by reported total.

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $10,565.0618

By program year

Program yearAmountRecords
2019 $10,565.0618

Records — PY2019 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
658404427 Janssen Pharmaceuticals, Inc $4,040.00 12/07/2019 Consulting Fee Undisputed 01/23/2026 View at CMS
658404431 Janssen Pharmaceuticals, Inc $992.52 12/07/2019 Travel and Lodging Undisputed 01/23/2026 View at CMS
658404437 Janssen Pharmaceuticals, Inc $43.10 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658404441 Janssen Pharmaceuticals, Inc $12.93 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658404445 Janssen Pharmaceuticals, Inc $30.17 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658404448 Janssen Pharmaceuticals, Inc $12.93 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658404451 Janssen Pharmaceuticals, Inc $57.00 12/07/2019 Travel and Lodging Undisputed 01/23/2026 View at CMS
658404455 Janssen Pharmaceuticals, Inc $47.36 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658404461 Janssen Pharmaceuticals, Inc $46.52 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
708403679 Janssen Pharmaceuticals, Inc $4,040.00 12/07/2019 Consulting Fee Undisputed 01/23/2026 View at CMS
708403681 Janssen Pharmaceuticals, Inc $992.52 12/07/2019 Travel and Lodging Undisputed 01/23/2026 View at CMS
708403683 Janssen Pharmaceuticals, Inc $12.93 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
708403685 Janssen Pharmaceuticals, Inc $43.10 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
708403687 Janssen Pharmaceuticals, Inc $12.93 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
708403689 Janssen Pharmaceuticals, Inc $30.17 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
708403691 Janssen Pharmaceuticals, Inc $57.00 12/07/2019 Travel and Lodging Undisputed 01/23/2026 View at CMS
708403693 Janssen Pharmaceuticals, Inc $46.52 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
708403695 Janssen Pharmaceuticals, Inc $47.36 12/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.